Alireza Raissadati

aliraissadati.bsky.social

04 May 2026 16:59

🌟 I'm thrilled to receive the 2026 AHA Career Development Award to support my work on next-generation liquid biopsies for non-invasive cardiac disease profiling! Enormous thanks to my mentors and Drs. Sean Wu and Kiran Khush. Excited for what's ahead.🚀 @ahascience.bsky.social @seanmwu.bsky.social

Emily R. Trunnell, Ph.D.

ertrunnell.bsky.social

04 May 2026 16:59

By Jin et al., incl. @seanmwu.bsky.social, it can be used to study early heart development, congenital heart disease mechanisms, & therapeutic strategies. 🏛️ also @emorycollege.bsky.social, @tamu.bsky.social, @notredame.bsky.social, @mcgovernpeds.bsky.social, @stanfordcvi.bsky.social #CardioSky

Han Zhu

hanzhumd.bsky.social

21 September 2025 06:48

It was great working with @seanmwu.bsky.social and @aliraissadati.bsky.social on this seminal work investigating the proof of concept use cell free mRNA biomarkers in ici myocarditis, a technology that can be expanded to other CV diseases! @stanfordmedicine.bsky.social @scvi-mavens.bsky.social

Journal of Clinical Investigation

jci.org

21 September 2025 06:48

Immune checkpoint inhibitors have transformed cancer therapy, but adverse events such as myocarditis remain hard to diagnose. @aliraissadati.bsky.social @seanmwu.bsky.social & team offer a noninvasive, early-detection tool for ICI-induced myocarditis—plasma cf-mRNA profiling: buff.ly/fVioq2o

Journal of Clinical Investigation

jci.org

21 September 2025 06:47

ICYMI: Immune checkpoint inhibitors have transformed cancer therapy, but adverse events such as myocarditis remain hard to diagnose. @aliraissadati.bsky.social @seanmwu.bsky.social & team offer a noninvasive, early-detection tool for ICI-induced myocarditis—plasma cf-mRNA profiling: buff.ly/d7GpTU0